The 14th Annual Conference of the Clinical Infectious Diseases Society, CIDSCON 2024, was inaugurated today at the Hyderabad International Convention Centre (HICC) by Prof. (Dr.) Atul Goel, Director-General of Health Services (DGHS), Ministry of Health and Family Welfare, Government of India. The event, hosted by The Clinical Infectious Diseases Society (CIDS), brought together leading experts in the field of infectious diseases.
The inauguration ceremony was graced by notable figures including Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals Enterprise Ltd.; Dr. George M. Varghese, President of CIDS; Dr. Vasant Nagvekar, Secretary of CIDS; Dr. Ashwini Tayade, Treasurer of CIDS; Dr. Suneetha Narreddy, Organising Chairperson of CIDSCON 2024; Dr. Venkat Ramesh, Organising Secretary of CIDSCON 2024; and Dr. O.C. Abraham, Scientific Committee Chairman of CIDSCON 2024.
The conference serves as a crucial platform for discussing the latest advancements and challenges in the management of infectious diseases, with a particular focus on pressing public health issues in India. This year’s conference highlights two significant threats: Antimicrobial Resistance (AMR) and Emerging Infections.
Also Read: Hyderabad Celebrates Independence Day with a Historic Rally and Massive Flag Display
AMR, often referred to as a silent pandemic, is a growing concern with severe implications for global health. India faces one of the highest burdens of drug-resistant infections (DRIs) worldwide, with approximately 1 million AMR-associated deaths annually, contributing to an estimated 5 million deaths globally each year. Projections suggest that by 2050, AMR could cause up to 10 million deaths annually, surpassing cancer-related mortality.
The rise of AMR is primarily driven by the misuse and overuse of antibiotics, which compromises the effectiveness of many medical treatments. In India, Gram-negative bacteria such as Klebsiella species, Escherichia coli, and Acinetobacter species are major contributors to resistance. Notably, Extended Spectrum Beta-lactamases (ESBL) are present in 70-80% of cases involving E. coli and Klebsiella, with rapidly spreading carbapenem resistance leading to mortality rates as high as 40%.
The CIDSCON 2024 conference aims to address these critical issues through collaborative discussions and innovative strategies, reinforcing the importance of tackling AMR and emerging infections to safeguard public health.
(This story is sourced from a third-party syndicated feed. Raavi Media takes no responsibility or liability of any nature. Raavi Media management/ythisnews.com can alter or delete the content without notice for any reason.)
